Citadel Advisors »

Compass Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $259k 166k 1.56
2023-03-31 $145k 45k 3.27
2022-12-31 $313k 62k 5.03
2021-12-31 $106k 34k 3.16

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Compass Therapeutics

OrbiMed Advisors
Henderson Group
Blackstone Group
BlackRock
Vanguard Group
Vivo Capital
Blue Owl Capital Holdings
Avidity Partners Management
Baker Bros. Advisors
Monashee Investment Management
Millennium Management
Braidwell
Bank of New York Mellon
Connor, Clark & Lunn Investment Management
Charles Schwab Investment Management

View all funds holding Compass Therapeutics